Brands Can Now Query Your Digital Twin, Matching 69% of the Time

Digital twins are increasingly used in personalized medicine, allowing companies to create virtual replicas of patients.

Digital twin technology has been gaining traction in the pharmaceutical industry, particularly in personalized medicine.

Companies can create virtual replicas of patients to simulate treatment outcomes and tailor medication to individual needs.

A recent report suggests that digital twins can accurately match real patients in 69% of cases, allowing brands to query and analyze virtual replicas with increasing confidence.